Current Pharmaceutical Biotechnology

Editor-in-Chief:

Davide Prosperi
Department of Biotechnology and Bioscience
University of Milan Bicocca
Milano
Italy

Back

Become EABM
Become Reviewer

Editorial [Hot Topic: Novel High Through-put Approach and Molecular Modelling in Drug Discovery from Natural Products and Clinical Implications] promotion: free to download

Volume:13   Issue: 9
Pp: 1631-1631
Chun Guang Li
DOI: 10.2174/138920112800958841

Pharmacophore, QSAR, and Binding Mode Studies of Substrates of Human Cytochrome P450 2D6 (CYP2D6) Using Molecular Docking and Virtual Mutations and an Application to Chinese Herbal Medicine Screening

Volume:13   Issue: 9
Pp: 1640-1704
Sui-Lin Mo, Wei-Feng Liu, Chun-Guang Li, Zhi-Wei Zhou, Hai-Bin Luo, Helen Chew, Jun Liang and Shu-Feng Zhou
DOI: 10.2174/138920112800958779

Editorial [Hot Topic: Oncolytic viruses] promotion: free to download

Volume:13   Issue: 9
Pp: 1731-1731
William Jia
DOI: 10.2174/138920112800958797

Attenuated Oncolytic Measles Virus Strains as Cancer Therapeutics

Volume:13   Issue: 9
Pp: 1732-1741
P. Msaouel, I. D. Iankov, A. Dispenzieri and E. Galanis
DOI: 10.2174/138920112800958896

Pro-Oncogenic Cell Signaling Machinery as a Target for Oncolytic Viruses

Volume:13   Issue: 9
Pp: 1742-1749
Emma Borrego-Diaz, Rajesh Mathew, Dana Hawkinson, Tuba Esfandyari, Zhengian Liu, Patrick W Lee and Faris Farassati
DOI: 10.2174/138920112800958788

Oncolytic Viruses for Induction of Anti-Tumor Immunity

Volume:13   Issue: 9
Pp: 1750-1760
Alex W. Tong, Neil Senzer, Vincenzo Cerullo, Nancy Smyth Templeton, Akseli Hemminki and John Nemunaitis
DOI: 10.2174/138920112800958913

Strategy of Cancer Targeting Gene-Viro-Therapy (CTGVT) a Trend in Both Cancer Gene Therapy and Cancer Virotherapy

Volume:13   Issue: 9
Pp: 1761-1767
Xin -Yuan Liu, Hua -Guang Li, Kang -Jian Zhang and Jin -Fa Gu
DOI: 10.2174/138920112800958869

Targeted and Armed Oncolytic Poxviruses for Cancer: the Lead Example of JX-594

Volume:13   Issue: 9
Pp: 1768-1772
Caroline J. Breitbach, Steve H. Thorne, John C. Bell and David H. Kirn
DOI: 10.2174/138920112800958922

Fusogenic Oncolytic Herpes Simplex Viruses as a Potent and Personalized Cancer Vaccine

Volume:13   Issue: 9
Pp: 1773-1785
Qi-Xiang Li, Guohong Liu and Xiaoliu Zhang
DOI: 10.2174/138920112800958832

Targeted Oncolytic Herpes Simplex Viruses for Aggressive Cancers

Volume:13   Issue: 9
Pp: 1786-1794
Jennifer Wong, Cleo Lee, Kevin Zhang, Paul S. Rennie and William Jia
DOI: 10.2174/138920112800958751

The Molecular Basis of Herpesviruses as Oncolytic Agents

Volume:13   Issue: 9
Pp: 1795-1803
Laura Menotti, Gabriella Campadelli-Fiume, Patrizia Nanni, Pier Luigi Lollini and Carla De Giovanni
DOI: 10.2174/138920112800958931

Mining the Adenovirus "Virome" for Systemic Oncolytics

Volume:13   Issue: 9
Pp: 1804-1808
Michael A. Barry, Eric A. Weaver and Christopher Y. Chen
DOI: 10.2174/138920112800958823

Synergistic Interaction of Telomerase-Specific Oncolytic Virotherapy and Chemotherapeutic Agents for Human Cancer

Volume:13   Issue: 9
Pp: 1809-1816
Toshiyoshi Fujiwara, Shunsuke Kagawa and Hiroshi Tazawa
DOI: 10.2174/138920112800958887

Bugs and Drugs: Oncolytic Virotherapy in Combination with Chemotherapy

Volume:13   Issue: 9
Pp: 1817-1833
Sonia Tusell Wennier, Jia Liu and Grant McFadden
DOI: 10.2174/138920112800958850

Recent Clinical Experience with Oncolytic Viruses

Volume:13   Issue: 9
Pp: 1834-1841
O. G. Donnelly, F. Errington-Mais, R. Prestwich, K. Harrington, H. Pandha, R. Vile and A. A. Melcher
DOI: 10.2174/138920112800958904

Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress

Volume:13   Issue: 9
Pp: 1842-1851
Balveen Kaur, E. Antonio Chiocca and Timothy P. Cripe
DOI: 10.2174/138920112800958814

Clinical Development of Oncolytic Viruses in China

Volume:13   Issue: 9
Pp: 1852-1857
Min Liang
DOI: 10.2174/138920112800958760